← Alle ReferenzenBeratungMarinomed Biotech AGgoetzpartners securities advised on Marinomed Biotech's initial public offering of eur 22.4 million (gross proceeds amount to eur 19.5 million excl. over-allotments/greenshoe)Ähnliches Mandat besprechen →BeratungKategorie2019Jahr€ 22,4 Mio.Deal-WertATLänder2019BeratungHealthcare and Life SciencesBeteiligtegoetzpartners advised